102 related articles for article (PubMed ID: 23624993)
1. Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded, parallel intervention study.
Idorn T; Knop FK; Jørgensen M; Jensen T; Resuli M; Hansen PM; Christensen KB; Holst JJ; Hornum M; Feldt-Rasmussen B
BMJ Open; 2013; 3(4):. PubMed ID: 23624993
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: the Lira-1 study.
Dejgaard TF; Knop FK; Tarnow L; Frandsen CS; Hansen TS; Almdal T; Holst JJ; Madsbad S; Andersen HU
BMJ Open; 2015 Apr; 5(4):e007791. PubMed ID: 25838513
[TBL] [Abstract][Full Text] [Related]
3. Effect of liraglutide on body weight and pain in patients with overweight and knee osteoarthritis: protocol for a randomised, double-blind, placebo-controlled, parallel-group, single-centre trial.
Gudbergsen H; Henriksen M; Wæhrens EE; Overgaard A; Bliddal H; Christensen R; Boesen MP; Knop FKK; Astrup A; Rasmussen MU; Bartholdy C; Daugaard C; Bartels EM; Ellegaard K; Heitmann BL; Kristensen LE
BMJ Open; 2019 May; 9(5):e024065. PubMed ID: 31061017
[TBL] [Abstract][Full Text] [Related]
4. Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist--protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocol.
Ishøy PL; Knop FK; Broberg BV; Baandrup L; Fagerlund B; Jørgensen NR; Andersen UB; Rostrup E; Glenthøj BY; Ebdrup BH
BMJ Open; 2014 Jan; 4(1):e004158. PubMed ID: 24401727
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Liraglutide in Patients With Type 2 Diabetes and End-Stage Renal Disease: An Investigator-Initiated, Placebo-Controlled, Double-Blind, Parallel-Group, Randomized Trial.
Idorn T; Knop FK; Jørgensen MB; Jensen T; Resuli M; Hansen PM; Christensen KB; Holst JJ; Hornum M; Feldt-Rasmussen B
Diabetes Care; 2016 Feb; 39(2):206-13. PubMed ID: 26283739
[TBL] [Abstract][Full Text] [Related]
6. The effect of a glucagon-like peptide-1 receptor agonist on glucose tolerance in women with previous gestational diabetes mellitus: protocol for an investigator-initiated, randomised, placebo-controlled, double-blinded, parallel intervention trial.
Foghsgaard S; Vedtofte L; Mathiesen ER; Svare JA; Gluud LL; Holst JJ; Damm P; Knop FK; Vilsbøll T
BMJ Open; 2013 Oct; 3(10):e003834. PubMed ID: 24176797
[TBL] [Abstract][Full Text] [Related]
7. Protocol for a randomised, double-blinded, placebo-controlled, double-dummy 6-week clinical trial comparing the treatment effects of the glucagon-like peptide 1 receptor agonist liraglutide versus the bile acid sequestrant colesevelam on bile acid malabsorption.
Kårhus ML; Brønden A; Lyng Forman J; Haaber A; Vilsbøll T; Sonne DP; Knop FKK
BMJ Open; 2021 Feb; 11(2):e044711. PubMed ID: 33558360
[TBL] [Abstract][Full Text] [Related]
8. Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocol.
Anholm C; Kumarathurai P; Klit MS; Kristiansen OP; Nielsen OW; Ladelund S; Madsbad S; Sajadieh A; Haugaard SB;
BMJ Open; 2014 Jul; 4(7):e005942. PubMed ID: 25031198
[TBL] [Abstract][Full Text] [Related]
9. A protocol for a randomised, double-blind, placebo-controlled study of the effect of LIraglutide on left VEntricular function in chronic heart failure patients with and without type 2 diabetes (The LIVE Study).
Jorsal A; Wiggers H; Holmager P; Nilsson B; Nielsen R; Boesgaard TW; Kumme A; Møller JE; Videbæk L; Kistorp C; Gustafsson I; Tarnow L; Flyvbjerg A
BMJ Open; 2014 May; 4(5):e004885. PubMed ID: 24844271
[TBL] [Abstract][Full Text] [Related]
10. Protocol for a randomised controlled trial of the combined effects of the GLP-1 receptor agonist liraglutide and exercise on maintenance of weight loss and health after a very low-calorie diet.
Jensen SBK; Lundgren JR; Janus C; Juhl CR; Olsen LM; Rosenkilde M; Holst JJ; Stallknecht BM; Madsbad S; Torekov SS
BMJ Open; 2019 Nov; 9(11):e031431. PubMed ID: 31678947
[TBL] [Abstract][Full Text] [Related]
11. Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial.
Armstrong MJ; Barton D; Gaunt P; Hull D; Guo K; Stocken D; Gough SC; Tomlinson JW; Brown RM; Hübscher SG; Newsome PN;
BMJ Open; 2013 Nov; 3(11):e003995. PubMed ID: 24189085
[TBL] [Abstract][Full Text] [Related]
12. Nocturnal antihypertensive treatment in patients with type 1 diabetes with autonomic neuropathy and non-dipping of blood pressure during night time: protocol for a randomised, placebo-controlled, double-blind, two-way crossover study.
Hjortkær H; Jensen T; Kofoed K; Mogensen U; Køber L; Hilsted KL; Corinth H; Theilade S; Hilsted J
BMJ Open; 2014 Oct; 4(10):e006142. PubMed ID: 25293387
[TBL] [Abstract][Full Text] [Related]
13. The effect of empagliflozin on oxidative nucleic acid modifications in patients with type 2 diabetes: protocol for a randomised, double-blinded, placebo-controlled trial.
Larsen EL; Cejvanovic V; Kjær LK; Vilsbøll T; Knop FK; Rungby J; Poulsen HE
BMJ Open; 2017 May; 7(5):e014728. PubMed ID: 28490557
[TBL] [Abstract][Full Text] [Related]
14. Study protocol: long-term effect of the New Nordic Renal Diet on phosphorus and lipid homeostasis in patients with chronic kidney disease, stages 3 and 4: a randomised controlled trial.
Hansen NM; Rix M; Kamper AL; Feldt-Rasmussen B; Christoffersen C; Astrup A; Salomo L
BMJ Open; 2021 Aug; 11(8):e045754. PubMed ID: 34462278
[TBL] [Abstract][Full Text] [Related]
15. Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation.
Bizino MB; Jazet IM; de Heer P; van Eyk HJ; Dekkers IA; Rensen PCN; Paiman EHM; Lamb HJ; Smit JW
Diabetologia; 2020 Jan; 63(1):65-74. PubMed ID: 31690988
[TBL] [Abstract][Full Text] [Related]
16. Study protocol of the randomised placebo-controlled GLOBE trial:
Hulst AH; Visscher MJ; Godfried MB; Thiel B; Gerritse BM; Scohy TV; Bouwman RA; Willemsen MGA; Hollmann MW; DeVries JH; Preckel B; Hermanides J
BMJ Open; 2018 Jun; 8(6):e022189. PubMed ID: 29866735
[TBL] [Abstract][Full Text] [Related]
17. Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial).
Jürgens M; Schou M; Hasbak P; Kjær A; Wolsk E; Zerahn B; Wiberg M; Brandt NH; Gæde PH; Rossing P; Faber J; Inzucchi S; Gustafsson F; Kistorp CM
BMJ Open; 2019 Nov; 9(11):e029098. PubMed ID: 31780586
[TBL] [Abstract][Full Text] [Related]
18. Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial.
von Herrath M; Bain SC; Bode B; Clausen JO; Coppieters K; Gaysina L; Gumprecht J; Hansen TK; Mathieu C; Morales C; Mosenzon O; Segel S; Tsoukas G; Pieber TR;
Lancet Diabetes Endocrinol; 2021 Apr; 9(4):212-224. PubMed ID: 33662334
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes.
Smits MM; Tonneijck L; Muskiet MH; Hoekstra T; Kramer MH; Pieters IC; Cahen DL; Diamant M; van Raalte DH
BMJ Open; 2015 Nov; 5(11):e009579. PubMed ID: 26586327
[TBL] [Abstract][Full Text] [Related]
20. Randomised, open-label, multicentre trial comparing haemodialysis plus haemoperfusion versus haemodialysis alone in adult patients with end-stage renal disease (HD/HP vs HD): study protocol.
Lu W; Jiang GR;
BMJ Open; 2018 Jul; 8(7):e022169. PubMed ID: 30056391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
